Clinical Trials

UVA Health System frequently opens new clinical trials, offering your patients the latest investigational treatments.

For a complete list of active cancer trials and study coordinator contact information, visit our newly launched Find a Clinical Trial website. If you have patients who may be eligible to participate in a cancer clinical trial, please email




New Trials Available at UVA

Thoracic Oncology IRB-HSR #19883

A Phase II Study of Olaparib Plus Cediranib in Combination with Standard Therapy for Small Cell Lung Cancer

Primary Investigator: Richard Hall
Clinical Research Coordinator: Maria Davenport

Graft-Versus-Host Disease IRB-HSR #20051

GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

Primary Investigator: Leonid Volodin
Clinical Research Coordinator: Michelle Bailey

Melanoma (IRB-HSR #18537)

Low-dose Interleulin-2 and Pembrolizumab Among Patients with Metastatic Melanoma and Renal Cell Carcinoma

Primary Investigator: William Grosh
Clinical Research Coordinator: Alex Carney

GI Oncology (IRB-HSR #20044)

Preeoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas (NCT02839343)

Primary Investigator: Tri Le
Clinical Research Coordinator: Susan Jones

Metastatic Cervical Cancer (IRB-HSR #20118)

A Phase 2 Study of Atezolizumab (MPDL3280A) in Combination with Bevacizumab in Patients with Recurrent, Persistent or Metastatic Cervical Cancer

Primary Investigator: Leigh Cantrell
Clinical Research Coordinator: Anne Gabel

Hematologic Malignancies (IRB-HSR #20170)

A 2-stage Study of Pracinostat + Azacitidine In Patients With High/Very High Risk of MDS By R-IPSS Who Are Candidates For Azacitidine Treatment

Primary Investigator: Michael Keng
Clinical Research Coordinator: Amelia Hodson